Print

9.0 Quality Assurance of HCV Testing

Posted in: HCV

For more information and background on HCV IVD regulation and quality assurance, refer to the TGA.

9.1 Laboratories

Laboratories that perform HCV testing:

  • must be NATA accredited for medical testing;47
  • must participate in an external quality assessment scheme (EQAS);48
  • must comply with the National Pathology Accreditation Advisory Council (NPAAC) standards;49 and
  • should contribute testing statistics to National Serology Reference Laboratory (NRL) to ensure the completeness of test denominator data.17

9.2 Pre-marketing quality assurance of HCV IVDs.

The TGA has regulatory responsibility for IVDs through the Therapeutic Goods Act 1989 (the Act) and its associated regulations.50

9.3 Post-marketing quality assurance of HCV IVDs

IVD manufacturers, sponsors and the TGA have responsibility for post-market monitoring of the IVDs. Corrective action must be initiated by the manufacturer and sponsor of an IVD in consultation with the TGA. This must occur as soon as practicable after becoming aware of information relating to any adverse events, malfunction or deterioration in the performance, or inadequacy in the design production and labelling of an IVD. Users are encouraged to report any issues with an IVD to the sponsor and the TGA. Reports to the TGA can be submitted through the TGA’s Incident Reporting Investigation Scheme (IRIS).  https://www.tga.gov.au/medical-device-incident-reporting-investigation-scheme-iris

Quick links to resources on this page

National Association of Testing Authorities Australia

NRL External Quality Assessment Schemes

NPAAC: Requirements for Laboratory Testing

Therapeutic Goods Act 1989

47. National Association of Testing Authorities Australia (NATA). Available at: http://www.nata.asn.au/ publications/section/1-accreditation_publications (Updated 2012; cited 23 March 2012).
48. National Reference Laboratory (NRL). External Quality Assessment Schemes (EQAS) for serology and nucleic acid testing (NAT) for blood-borne and sexually transmitted infections. Available at: http://www.nrl.gov.au/Our+Services/Quality+Assurance/External+Quality+Assessment+Schemes+ (EQAS) (Cited 23 March 2012).
49. Australian Government Department of Health and Ageing. National Pathology Accreditation Advisory Council (NPAAC). Requirements for Laboratory Testing for Human Immunodeficiency Virus (HIV) and Hepatitis C Virus (HCV). Second edition 2009. Available at: http://www.health.gov.au/ internet/main/publishing.nsf/Content/1210EF5BABF74134CA2571A10028C604/$file/ Requirements%20for%20Lab%20Testing%20for%20HIV%20and%20HCV%20
%28Second%20Edition%202009%29-final%20version-printing-27%20Nov%202009.doc.pdf
(Cited 23 March 2012).
50. Australian Government. ComLaw. Therapeutic Goods Act 1989. C2011C00379. Available at:
http://www.comlaw.gov.au/Details/C2011C00379 (Cited 23 March 2012).

Download HCV Testing Policy

Download the full
2017 National HCV Testing Policy v1.2 (PDF, 1.1MB)

See what's changed from previous version -->

 

 ASHM_LOGO_

Development of this site and the 2014 and 2017 revisions of the testing policies was supported by: Australian Government Department of Health and Ageing